Nodal involvement, tumour size, histological malignancy grade and nuclear grade (Fisher et al., 1980 (Fisher et al., , 1983 (Fisher et al., , 1984 Bloom, 1957; Wallgren et al., 1976; Blanco, 1980) as well as oestrogen (ER) and progesterone (PR) receptor measurements (Osborne et al., 1980 , Blamey et al., 1980 Blanco et al., 1984) and DNA flow cytometric analyses (Cornelisse et al., 1987; Kallioniemi et al., 1987 Kallioniemi et al., , 1988 are the most important parameters used for the prognostic evaluation of primary breast cancer. However, the value of these prognostic factors, in cases of recurrent breast cancer, to define post-relapse survival is not well established.
Although observations on prognostic determinants influencing the behaviour of metastases from breast cancer are scarce, some information on the behaviour of such metastases emerges from evaluations of efforts at therapy in different subsets of patients. Thus a significant correlation has been found between the dominant site of recurrence and the final outcome of the disease. A poor prognosis for liver metastases, visceral and multiple involvement, as well as for brain metastases, have been proved repeatedly (Fey et al., 1981; Nash et al., 1982; Valagussa et al., 1979; Nikkanen, 1981; Di Stefano et al., 1979; Davidson et al., 1984) , while better prognoses have been found for bone and soft tissue metastases (Hietanen, 1986; Clark et al., 1987) . One important parameter reflecting the aggressiveness of the disease is the time from diagnosis to the appearance of the recurrence. This parameter has repeatedly proved to be one of the most useful for assessing the behaviour of the disease (Cutler et al., 1969; Devitt et al., 1971; Pater et al., 1981; Hietanen, 1987) .
It has been found more recently that recurrences among ER-negative patients tend to be in the viscera, soft tissues and brain, whereas ER-positive patients are more likely to have recurrences in bone (Stewart et al., 1981; Clark et al., 1987) . This relation between recurrences at specific sites and ER could not be confirmed by other authors (Kamby et al., 1986) . This report seeks to identify prognostic determinants that rule the behaviour of recurrences stemming from breast cancer. The selected prognostic variables for this study were:
(1) site of the first recurrence, (2) disease-free interval (DFI), (3) primary ER and PR measurements The methods used to evaluate ER and PR have been reported elsewhere (Vihko et al., 1980) . In order to evaluate the relationship between the concentration of ER and PR in the primary tumour and the first site of metastases, the cases were arbitrarily divided into groups according to their ER and PR concentrations as follows: the first group contained cases in which ER was considered negative (<3 fmol mg-' cytosol protein), the second had concentrations between 3 and lOOfmolmg'I cytosol protein, and the third group had concentrations above 100 fmol mg-' cytosol protein. The PR groups were similarly divided, the first group containing PR-negative cases (<10 fmol mg ' cytosol protein), the second group, cases with PR concentrations between 10 and 100 fmol mg-' cytosol protein, and the third group with high concentrations of PR, > 100 fmol mg' cytosol protein.
Histological malignancy grading was performed according to the recommendations stated by the Classifications of Tumours of the Breast (WHO, 1968) .
DNA flow cytometric analysis was performed by processing paraffin embedded primary breast tumour specimens as previously described (Kallioniemi et al., 1987) . This analysis was performed in 226 cases.
Curves depicting survival from the first recurrence until December 1985 were constructed using the Kaplan-Meier (1958) product limit estimation. Similarities between the survival curves for the different groups were tested using the log-rank test (Mantel, 1966 ). Multivariate analysis was tested with Cox's proportional hazard model. Computations were performed using programs from the SAS statistical package on an IBM 3083 computer.
Results
Site of recurrence Of the 613 cases with primary breast cancer, 313 developed a recurrence after primary treatment. The highest frequency was observed in soft tissue, mainly in the skin (Table II) , and the next most frequent site was the viscera, whereas the brain was rare as the first site of recurrence, accounting for only 1.9% of all the recurrences observed. The worst survival rate was found in patients with visceral recurrences, with a median survival of 12 months, followed by bone metastasis, with a median survival of 19 months. The best prognosis was found for soft tissue recurrence, with a median survival of 32 months. The differences in the curves are statistically highly significant (P<0.0001) (Figure 1) .
Regardless of the initial site of recurrence, ER-positive patients survived longer than ER-negative patients, and a similar relationship was also noted among patients with PR positive tumours compared to PR-negative patients. The differences observed in the survival curves, when related to ER, do not quite reach statistical significance, but the survival difference for soft tissue and bony recurrence sites, when related to PR, was statistically significant (Figures 2  and 3 ). Disease-free interval (DFI) The patients with recurrent malignancies were divided into three groups: disease-free survival less than 1 year, 1-3 years and over 3 years. A longer survival period was observed in those patients who also had a longer DFI. The difference between the survival rates of these groups was highly significant (P<0.0001) (Figure 4 ).
Oestrogen and progesterone receptors The differences in the proportion of ER-positive and PRpositive cases between the groups defined according to the first site of metastasis were not statistically significant, (Table IV) . Furthermore, no significant difference was found between the DNA-diploid and DNA-aneuploid cases in terms of their survival curves ( Figure 5 ).
Histological malignancy grading
Histological grading has been considered, despite its limitations, as a valuable biological criterion for prognosis in primary breast cancer. Therefore the evaluation of histological grading was included in this study to define its importance to recurrent breast cancer. The survival of patients with grade II tumours lay in between. The differences between the survival curves were statistically significant (P = 0.0001) (Figure 6 ).
Multivariate analysis A multivariate analysis of the prognostic variables was intended. However, the proportion of single variables used in this material does not fit well with the Cox's proportional hazard model, mainly because of the unequal number of cases for the evaluation of each variable. The number of cases for the ploidy multivariate analysis was considerably smaller than the number of other variables and therefore ploidy was not included in the multivariate analysis. To obtain a greater number of cases for this analysis, histological grades I and II were arbitrarily pooled as were bone and viscera groups for first site of recurrence. After these modifications to the material the multivariate analysis shows that histological grading, recurrence-free survival time and site of primary recurrence are the most important predictive variables in recurrent breast cancer (Table V) .
Discussion
The present analysis of 313 cases of breast cancer which subsequently developed metastases shows that patients with soft tissue recurrences had a significantly better prognosis than those with bone metastases, and that patients with visceral metastases had the worst prognosis. The better prognosis for soft tissue recurrences is in general attributed to the earlier detection and better management or less aggres- siveness of such recurrences, whereas liver metastases, which are more common among histologically aggressive tumours, lead to a rapid progression of the disease (Cutler et al., 1969; Hietanen, 1987) . Another cause for the shorter survival of cases with visceral metastases may be the rapid impairment of the affected organs and their poor response to treatment (Hietanen, 1987) . A longer recurrence-free period and a better overall survival rate have been observed among breast cancer patients with postive ER and PR (Bishop et al., 1979; Osborne et al., 1980; Blamey et al., 1980; Blanco et al., 1984; Thorpe et al., 1986) . This finding has been regarded as an indication of a better response to hormonal therapy among such patients. A better survival rate was also seen here for the ER-positive patients than for the ER-negative ones, regardless of the site of recurrence. ER status also emerges as a prognostic variable upon recurrence of the disease, as described by Clark et al. (1987) . However, the value of PR as a prognostic determinant in recurrent breast cancer is nevertheless shown here to be stronger than that of ER.
The disease-free interval following the first recurrence is of great significance for survival (Cutler et al., 1969; Aberzik, 1986; Hietanen, 1987) , although there are also some reports to the contrary (Rosenman & Perrone, 1984) . The present patients, with a recurrence detected during the first year after diagnosis of the primary disease, fared extremely poorly compared with those whose recurrence was detected during the second year or later following diagnosis of their disease.
A number of authors have suggested that ER-positive tumours are more likely to recur in the bone and ERnegative ones in the viscera and the brain (Singhakowinta et al., 1976; Stewart et al., 1981; Clark et al., 1987 first recurrence is highly statistically significant in terms of the median concentrations of ER and PR in relation to the site of the first recurrence. The higher the concentrations of ER and PR, the more likely it is that the first recurrence will be in bone, whereas the lower the concentrations are, the higher the possibility of visceral metastases. Accordingly, the relationship between sex steroid hormone receptors and the first site of metastases not only depends on the presence or absence of receptors but seems to be closely dependent on the amounts of these receptors present. DNA ploidy evaluation of the primary tumour has proved to be a useful indicator for predicting the prognosis in patients with breast cancer (Hedley et al., 1984; Cornelisse et al., 1987; Kallioniemi et al., 1987) . The proportion of patients in this study with DNA diploid tumours who developed metastases in the course of their disease is significantly lower (29%) than that of patients with DNA aneuploid tumours (57%). Measurement of the DNA ploidy of the primary tumour is less useful, however, when related to the first site of recurrence, for the proportions of cases with DNA diploid tumours and DNA aneuploid tumours were similar regardless of the site of the first recurrenece. Nor do the survival curves show any differences between the groups.
Histological grading emerges in this study as a predictive variable, as was expected. However, the distribution of histological grades in the data set is not equal. The majority of the cases had histological grade III tumours, which have a high malignant potential, and account for the majority of the recurrent cases in breast cancer.
Multivariate analysis points to the same variables, histological grading, disease free-interval and site of recurrence, as the most valuable predictive factors in recurrent breast cancer. However, female sex steroid receptors also appear to have a specific role in recurrent breast cancer. Ploidy assessment, on the contrary, contributes less to the understanding of recurrent breast cancer.
